TANOX, INC.

Company Information

Company Name
TANOX, INC.
Address
10301 STELLA LINK RD
HOUSTON, TX, 77025
Phone
1 713-664-2288
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$410,846.00
7
SBIR Phase II
$985,449.00
2
Chart code to be here

Award List

  1. ANTI-IDIOTYPIC VACCINES FOR AIDS

    Amount: $500,000.00

    THE GEOMETRIC INCREASE IN THE NUMBER OF INDIVIDUALS INFECTED BY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) HAS CREATED SERIOUS SOCIAL, ECONOMICAL AND LIFE-THREATENING ISSUES TO THE HUMAN RACE. IT IS ...

    SBIR Phase II 1990 Department of Health and Human Services
  2. CHIMERIC CD4/IMMUNOGLOBULIN ANTIBODIES FOR AIDS

    Amount: $44,192.00

    ONE OF THE MOST URGENT CHALLENGES FACING THE MEDICAL COMMUNITY IS THE DEVELOPMENT OF EFFECTIVE THERAPEUTIC AGENTSFOR VICTIMS OF THE WORLDWIDE AIDS EPIDEMIC. BECAUSE OF THEIR HIGH DEGREE OF SPECIFICITY ...

    SBIR Phase I 1989 Department of Health and Human Services
  3. IMMUNOTOXIN THERAPY FOR AIDS

    Amount: $485,449.00

    THE GEOMETRIC INCREASE IN THE NUMBER OF INDIVIDUALS INFECTED BY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) HAS CREATED SERIOUS SOCIAL, ECONOMIC, AND LIFE-THREATENING ISSUES FOR THE HUMAN RACE. IT IS ...

    SBIR Phase II 1991 Department of Health and Human Services
  4. EXPRESSION OF AN ANTI-IDIOTYPIC FV FRAGMENT AS A VACCINE FOR AIDS

    Amount: $49,884.00

    TANOX BIOSYSTEMS, INC., HAS GENERATED AN ANTI-IDIOTYPE (ID) MONOCLONAL ANTIBODY (MAB), AB19-4, TO THE HIV-1-NEUTRALIZING MAB, BAT123, WHICH RECOGNIZES AN IMMUNODOMINANT REGION OF GP120. RESEARCH HAS C ...

    SBIR Phase I 1990 Department of Health and Human Services
  5. ENHANCEMENT OF MUCOSAL IMMUNITY

    Amount: $50,000.00

    THE RATE OF HETEROSEXUAL TRANSMISSION OF HIV-1 THROUGH SEXUAL CONTACTS IS INCREASING IN MOST COUNTRIES. LIKE MANY OTHER PATHOGENIC MICROORGANISMS, HIV-1 VIRIONS ENTER THE BODY THROUGH MUCOSAL SURFACE ...

    SBIR Phase I 1992 Department of Health and Human Services
  6. Broad Cross-Reactivity of HIV-1 Neutralizing Antibody

    Amount: $75,000.00

    Passive immunization with broadly neutralizing antibodies is a promising approach for preventionand treatment of HIV-1 infection. We have generated an HIV-1 neutralizing human antibody which bindsto t ...

    SBIR Phase I 1994 Department of Health and Human Services
  7. N/A

    Amount: $100,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  8. IMMUNOTOXIN THERAPY FOR AIDS

    Amount: $46,770.00

    N/A

    SBIR Phase I 1989 Department of Health and Human Services
  9. ANTI-IDIOTYPIC VACCINES FOR AIDS

    Amount: $45,000.00

    N/A

    SBIR Phase I 1988 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government